Top compounds associated with response to AC110615.1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-07
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA SKI-II CTRPv2 pan-cancer AAC 0.12 0.001
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.096 0.001
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA phloretin CTRPv2 pan-cancer AAC 0.11 0.002
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV